Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STK17B | O94768 | 1/20 | 0.41 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | LATS1 | O95835 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 7/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2846431 | 0.93 | STK17B (0.45) | STK17BSTK17AGAAMEN1KMT2A | |
| SCHEMBL2364441 | 0.89 | STK17B (0.40) | STK17BSTK17AGAAMEN1KMT2A | |
| SCHEMBL2842705 | 0.88 | STK17B (0.47) | STK17BSTK17AGAAMEN1KMT2A | |
| SCHEMBL2838329 | 0.86 | BCHE (0.48) | STK17BSTK17AGAAMEN1KMT2A | |
| SCHEMBL16748721 | 0.85 | SIRT5 (0.39) | KMT2AKDM4EALDH1A1 | |
| SCHEMBL13531612 | 0.80 | STK17B (0.46) | STK17BSTK17AGAAMEN1KMT2A | |
| Succinic Acid SCHEMBL29429364 | 0.77 | GAA (0.56) | GAAMEN1KMT2ABCHETDP1 | |
| SCHEMBL2849313 | 0.76 | BCHE (0.48) | GAAMEN1KMT2ABCHEBRD4 | |
| SCHEMBL156911 | 0.76 | GAA (0.58) | GAAMEN1KMT2ATDP1MALT1 | |
| SCHEMBL13510973 | 0.75 | TDP1 (0.41) | STK17BSTK17AGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150147277-A1 | COMPOSITIONS AND METHODS FOR ASSESSING GUT FUNCTION | MEDIBEACON INC. | 2015-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150147277-A1 | COMPOSITIONS AND METHODS FOR ASSESSING GUT FUNCTION | FABP2, SLC10A2, SI | STK17B 4521/4885STK17A 4033/4885GAA 1587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.